Ackermann S Schoenenberger CA Zanetti-Dällenbach R 2016 PURPOSE Ultrasound (US) is a well-established diagnostic procedure for breast examination. We investigated the malignancy rate in solid breast lesions according to their BI-RADS classification with a particular focus on false-negative BI-RADS 3 lesions. We examined whether patient history and clinical findings could provide additional information that would help determine further diagnostic steps in breast lesions. MATERIALS AND METHODS We conducted a retrospective study by exploring US BI-RADS in 1469 breast lesions of 1201 patients who underwent minimally invasive breast biopsy (MIBB) from January 2002 to December 2011. RESULTS The overall sensitivity and specificity of BI-RADS classification was 97.4% and 66.4%, respectively, with a positive (PPV) and negative predictive value (NPV) of 65% and 98%, respectively. In 506 BI-RADS 3 lesions, histology revealed 15 malignancies (2.4% malignancy rate), which corresponds to a false-negative rate (FNR) of 2.6%. Clinical evaluation and patient requests critically influenced the further diagnostic procedure, thereby prevailing over the recommendation given by the BI-RADS 3 classification. CONCLUSION Clinical criteria including age, family and personal history, clinical examination, mammography and patient choice ensure adequate diagnostic procedures such as short-term follow-up or MIBB in patients with lesions classified as US-BI-RADS 3. application/pdf https://sonar.ch/global/documents/231953 eng info:eu-repo/semantics/altIdentifier/doi/10.1055/s-0042-110657 info:eu-repo/semantics/altIdentifier/pmid/27689181 info:eu-repo/semantics/openAccess Ultrasound international open. - 2016 BI-RADS breast cancer breast ultrasound cancer rate false-negative Clinical Data as an Adjunct to Ultrasound Reduces the False-Negative Malignancy Rate in BI-RADS 3 Breast Lesions. http://purl.org/coar/resource_type/c_6501